AIZ vs PBYI · P/E 15, rev $3.45B vs P/E 4.3, rev $56.5M
Assurant Inc (AIZ) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the AIZ and PBYI stock pages for the full models.
Not investment advice.